270 Protein Engineering IV: Therapeutics II

Tuesday, November 5, 2013: 8:30 AM
Golden Gate 4 (Hilton)
Description:
This session will focus on protein engineering for therapeutic applications, with an emphasis on emerging topics and recent successes. Potential areas of interest include, but are not limited to, (1) advances in protein-based therapeutics, (2) proteins for cell targeting and imaging, and (3) proteins involved in disease pathology.

Sponsor:
Bioengineering

Chair:
Yvonne Chen
Email: yvchen@ucla.edu

Co-Chair:
Mark A. Blenner
Email: blenner@clemson.edu


8:30 AM
(270a) Engineering and Analysis of Antibody Fragments for Prion Disease Therapy
Kyle M. Doolan and David W. Colby

8:48 AM
(270b) Design of Antibodies Specific for Misfolded Proteins
Joseph M. Perchiacca, Swarnim Ranjan, Christine Lee, Kathryn Tiller, Mark Julian, Fanling Meng and Peter M. Tessier

9:06 AM
(270c) De Novo Computational Design of Fully-Human Antibody Variable Domains
Costas D. Maranas and Robert J. Pantazes

9:24 AM
(270d) Computationally Driven Deimmunization of Therapeutic Proteins
Regina S. Salvat, Andrew S. Parker, Chris Bailey-Kellogg and Karl E. Griswold

9:42 AM
(270e) Engineered Biosensor Proteins for Programming Novel Therapeutic Modalities
Rachel M. Dudek, Nichole Daringer and Joshua N. Leonard

10:00 AM
(270f) Evaluation of Three Vascular-Targeted Enzyme Prodrug Systems for Breast Cancer Therapy
John Krais, Brent Van Rite, Carla Kurkjian and Roger Harrison

10:18 AM
(270g) Engineering Nanog Protein for Effective Protein Transduction: A Possible Alternative to Reverse the Effects of Organismal Aging On Mesenchymal Stem Cells
Mao-Shih Liang, SeoYoung Son, Satrajit Sinha and Stelios T. Andreadis

10:36 AM
(270h) Encapsulation and Delivery of Biomolecular Therapeutics Using the Bacteriophage MS2 Viral Capsid
Jeff Glasgow, Matthew Francis and Danielle Tullman-Ercek
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division
<< Previous Session | Next Session >>